On Saturday, Rami Elghandour learned that the university had canceled his speech following complaints over his social media ...

Since then, Odyssey has had no problems bringing in the megarounds. As well as the $218 million that the company launched ...

Novo Nordisk’s CEO has insisted that plans to launch the GLP-1/amylin combo treatment CagriSema remain on track, despite the ...

Here's why former Forge CEO Tim Miller has licensed a gene therapy (again) from Nationwide Children's for "unfinished ...

(Michael on for Roanna Ruiz), Leerink Partners: "what would constitute a clear signal as a green light to initiate Phase III in 2027?"; President, CEO & Director De Backer: "it's going to really be ...

The CEO called the talks “exceptionally constructive” and said the engagement was a “meaningful recognition” of the company’s work. ・Investor focus remains on the Phase 3 Regal trial evaluating GPS ...

REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company developing next-generation cancer therapies, today announced that Gil Efron, Chief ...

©2026 FOX News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.

Sunnier conditions in the forecast after ‘Biotech Winter?’ Participants in the BizWest’s Life Sciences CEO Roundtable hosted by the University of Colorado Boulder’s BioFro ...

Marie Saavedra joined the CBS2 Chicago news team in October 2020 as an anchor. She grew up in Evanston and is a graduate of the Missouri School of Journalism. A CEO at a Chicago biotech company is ...